Removing Barriers to Colorectal Cancer Screening Act introduced: 5 things to know

The Removing Barriers to Colorectal Cancer Screening Act (HR 1220 and S 624) was introduced in the House and Senate, according to an AGA eDigest report. Here are five things to know about the legislation. 

Advertisement

1. The legislation aims to eliminate co-insurance for Medicare patients undergoing a screening colonoscopy that becomes therapeutic due to the presence of polyps that must be removed.

2. Representatives Charlie Dent (R-Pa.) and Donald Payne Jr. (D-N.J.) introduced HR 1220.

3. Senators Sherrod Brown (D-Ohio), Susan Collins (R-Maine), Ben Cardin (R-Md.), and Roger Wicker (R-Miss.) introduced S 624.

4. This is the first year that the Senate version of the bill has had significant bipartisan support.

5. “AGA applauds the sponsors of this legislation for their leadership in introducing the Removing Barriers to CRC Screening Act and for their tireless efforts in increasing awareness as to the importance of screening,” said John I. Allen, MD, MBA, president of the AGA Institute, according to the report.

More articles on gastroenterology:
PPACA repeal: How would gastroenterologists be impacted?
Mid-South Gastroenterology Group partnerships aim to increase colonoscopies
North Texas Endoscopy Centers offer free colonoscopy screenings for 50 uninsured people

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.